The United States Professional Association for Transgender Health (USPATH) is the United States affiliate of the transgender advocacy organization World Professional Association for Transgender Health (WPATH). All members of WPATH who live in the United States are automatically members of USPATH. ^{1  2}

Background and Activities

The United States Professional Association for Transgender Health (USPATH) is the United States affiliate of the World Professional Association for Transgender Health (WPATH), a medical advocacy group made up of doctors who seek to standardize medical practices concerning treatments for gender dysphoria. USPATH operates under the umbrella of WPATH and provides a forum for professionals practicing transgender-related medicine in the U.S. to share research, clinical experience, and practices. Professionals in the U.S. who are WPATH members are automatically members of USPATH. ^{1   2}

USPATH was launched in 2017 with an inaugural conference, sponsored in association with WPATH, held in February  which focused on health care practices that “affirm” transgender individuals’ desired sex. Since 2017, USPATH has continued to host conferences and symposiums that support such medical practices. A symposium held in 2025 included discussions on land acknowledgment, policies that affect transgender health, and sessions on issues such as LGBT curricula “through an intersectional lens.” Other sessions held were on “the future of gender-affirming medical education,” “building a gender affirming care model in the emergency Department,” reproductive care for those who identify as non-binary, exercises for “vocal feminization,” health equity, “fostering gender literacy and centering trans joy in young children,” and promoting the participation of transgender people in athletics. ^{3  4}

In May 2025, USPATH criticized a report released by the U.S. Department of Health and Human Services (HHS) report that called for the use of psychotherapy for the treatment of gender dysphoria instead of using puberty-blocking cross-sex hormones.  ^{5  6}

Leadership

Jo (Johanna) Olson-Kennedy is the president of the board of directors for the United States Professional Association for Transgender Health (USPATH). Olson-Kennedy’s term as the president of the board runs from 2025 to 2027. Olson-Kennedy is the medical director of Prosilio. Previously, she was the medical director for the Center for Transyouth Health and Development for the Children’s Hospital of Los Angeles and the Southern California co-chair of the Progressive Caucus of the California Democratic Party. ^{7  8}

Carl Streed Jr. was the former president of USPATH. Streed was previously a research director of the GenderCare Center as well as a clinician-investigator for the Boston Medical Center. Steed is also an associate professor at the Boston University School of Medicine and a board member of the Point Foundation. Prior to this, he held several positions with the American Medical Association including delegate and later vice-chair of the LGBTQ+ section, the vice chair of the advisory committee on LGBTQ issues, representative to the board of trustees advisory committee on LGBTQ issues, and chair of the LGBT advisory committee. Streed was also the chair of the committee on LGBT matters for the Massachusetts Medical Society. He was the president of the World Professional Association for Transgender Health from November 2023 to October 2025. ^{7  9}

The executive at-large of USPATH as of 2025 is Kacie Kidd. ⁷

1. “USPATH.” WPATH. Accessed December 16, 2025. https://wpath.org/uspath/.
2. “Membership Information.” WPATH. December 16, 2025.
3. “Project AFFIRM presents at USPATH Symposium.” Project Affirm. February 6, 2017. Accessed December 16, 2025. https://www.projectaffirm.org/news/2017/2/6/project-affirm-presents-at-uspath-symposium.
4. “US Professional Association for Transgender Health Scientific Symposium.” WPATH. Accessed December 26, 2025. https://wpath.org/wp-content/uploads/2025/09/21279-USPATH-2025-Full-Schedule-r14.pdf.
5. “WPATH and USPATH Response to the HHS Report on Gender Dysphoria.” WPATH. May 2, 2025. Accessed December 16, 2025. https://wpath.org/wp-content/uploads/2025/05/WPATH-USPATH-Response-to-HHS-Report-02May2025-3.pdf.
6. “HHS Releases Comprehensive Review of Medical Interventions for Children and Adolescents with Gender Dysphoria.” U.S. Department of Health and Human Services. May 1, 2025. Accessed December 16, 2025. https://www.hhs.gov/press-room/gender-dysphoria-report-release.html.
7. “USPATH Board of Directors.” WPATH. Accessed December 16, 2025. https://wpath.org/uspath/board/.
8. “Johanna Olson-Kennedy (She/Her).” LinkedIn. Accessed December 16, 2025. https://www.linkedin.com/in/johanna-olson-kennedy-2652a8b/.
9. “Carl Streed Jr MD, MPH, FACP, FAHA (He/Him).” LinkedIn. Accessed December 16, 2025. https://www.linkedin.com/in/carlgstreedjr/details/experience/.